Free shipping on all orders over $ 500

AZD6765

Cat. No. M1897

All AbMole products are for research use only, cannot be used for human consumption.

AZD6765 Structure
Size Price Availability
10mg USD 180  USD180 Out of stock
50mg USD 480  USD480 Out of stock
200mg USD 900  USD900 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZD6765, a low-trapping NMDA channel blocker in development for major depression, is predicted to have an improved tolerability profile compared to ketamine. Preclinically, NMDA channel blockers increase gamma-band EEG - a potential therapeutic biomarker of cortical disinhibition. Significant increases in gamma-band EEG were observed at 1 hour for AZD6765 and ketamine, and baseline-corrected gamma-band EEG following AZD6765 150 mg was statistically indistinguishable from that observed following ketamine. AZD6765 demonstrated NMDA channel blockade and an improved tolerability profile compared to ketamine. AZD6765 demonstrated NMDA channel blockade and an improved tolerability profile compared to ketamine.

Chemical Information
Molecular Weight 198.26
Formula C13H14N2
CAS Number 153322-05-5
Form Liquid
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ioline D Henter, et al. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

[2] Vivian B Neis, et al. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765

[3] Samuel T Wilkinson, et al. A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems

[4] Ioline D Henter, et al. Glutamatergic Modulators in Depression

[5] Lorenz Deutschenbaur, et al. Role of calcium, glutamate and NMDA in major depression and therapeutic application

Related GluR Products
VU0650786

VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM.

NS-102

NS-102 is a selective kainate (GluK2) receptor antagonist.

VU0424465 

VU0424465 is a potent and partial PAM (positive allosteric modulator)-agonist for mGlu5 mediated iCa2+ mobilization.

ATPA 

ATPA is a selective glutamate receptor GluR5 activator with EC50s of 0.66, 9.5, 1.4, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S741M), GluR5(S721T), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V), respectively.

(R)-CPP 

(R)-CPP is a highly potent NMDA receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: AZD6765 supplier, GluR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.